ACADIAN ASSET MANAGEMENT LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 40 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$39,000
-98.5%
739
-98.2%
0.00%
-100.0%
Q2 2020$2,575,000
-57.8%
42,029
-63.1%
0.01%
-57.7%
Q3 2019$6,101,000
-32.3%
113,980
-21.2%
0.03%
-33.3%
Q1 2019$9,015,000
+1.0%
144,630
-1.8%
0.04%
-11.4%
Q4 2018$8,926,000
+11.8%
147,308
+7.9%
0.04%
+33.3%
Q3 2018$7,987,000
+60.5%
136,568
+23.1%
0.03%
+50.0%
Q2 2018$4,976,000
+2.9%
110,934
+1.7%
0.02%
+4.8%
Q1 2018$4,838,000
-0.5%
109,128
-2.8%
0.02%0.0%
Q4 2017$4,863,000
-17.2%
112,234
-11.1%
0.02%
-19.2%
Q3 2017$5,873,000
-28.1%
126,220
-23.5%
0.03%
-29.7%
Q2 2017$8,168,000
-19.3%
164,938
-10.7%
0.04%
-19.6%
Q1 2017$10,118,000
-5.0%
184,604
-3.4%
0.05%
-11.5%
Q4 2016$10,646,000
+11.3%
191,127
-8.7%
0.05%
+10.6%
Q3 2016$9,561,000
+10.6%
209,366
-3.3%
0.05%
+6.8%
Q2 2016$8,643,000
-6.9%
216,495
-18.8%
0.04%
-6.4%
Q1 2016$9,284,000
-19.6%
266,691
-0.8%
0.05%
-21.7%
Q4 2015$11,544,000
+1.7%
268,715
+3.1%
0.06%
-3.2%
Q3 2015$11,353,000
+12.2%
260,696
+32.9%
0.06%
+26.5%
Q2 2015$10,121,000
+43.8%
196,117
+9.1%
0.05%
+53.1%
Q1 2015$7,040,000
+18.1%
179,782
+16.4%
0.03%
+18.5%
Q4 2014$5,961,000
+80.1%
154,426
+64.6%
0.03%
+68.8%
Q3 2014$3,309,000
+92.3%
93,840
+47.1%
0.02%
+100.0%
Q2 2014$1,721,000
+115.7%
63,806
+107.0%
0.01%
+100.0%
Q1 2014$798,000
+82.2%
30,821
+52.3%
0.00%
+100.0%
Q4 2013$438,000
+36.9%
20,237
+23.2%
0.00%0.0%
Q3 2013$320,00016,4230.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2013
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders